Patent details

EP3830090 Title: 1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR

Basic Information

Publication number:
EP3830090
PCT Application Number:
US2019044575
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP197590904
PCT Publication Number:
WO2020028608
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
1H-PYRAZOLO[4,3-D]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR
French Title of Invention:
COMPOSÉS DE 1H-PYRAZOLO[4,3-D]PYRIMIDINE UTILISÉS EN TANT QU'AGONISTES DU RÉCEPTEUR 7 DE TYPE TOLL (TLR7) ET PROCÉDÉS ET UTILISATIONS ASSOCIÉS
German Title of Invention:
1H-PYRAZOLO[4,3-D]PYRIMIDINVERBINDUNGEN ALS TOLL-ÄHNLICHE REZEPTOREN 7 (TLR7)-AGONISTEN UND VERFAHREN UND VERWENDUNGEN DAFÜR
SPC Number:

Dates

Filing date:
01/08/2019
Grant date:
01/03/2023
EP Publication Date:
09/06/2021
PCT Publication Date:
06/02/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/03/2023
EP B1 Publication Date:
01/03/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/08/2023
Expiration date:
01/08/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/02/2023
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:
HE, Liqi
Address:
United States (US)

2

Name:
GANGWAR, Sanjeev
Address:
United States (US)

3

Name:
TARBY, Christine M.
Address:
United States (US)

4

Name:
CHOWDARI, Naidu S.
Address:
United States (US)

5

Name:
POUDEL, Yam B.
Address:
United States (US)

6

Name:
SIVAPRAKASAM, Prasanna
Address:
United States (US)

7

Name:
COX, Matthew
Address:
United States (US)

8

Name:
ZHANG, Qian
Address:
United States (US)

9

Name:
BROEKEMA, Matthias
Address:
United States (US)

Priority

1

Priority Number:
201862714238 P
Priority Date:
03/08/2018
Priority Country:
United States (US)

2

Priority Number:
201916527802
Priority Date:
31/07/2019
Priority Country:
United States (US)

Classification

IPC classification:
C07D 487/04; A61P 35/00; A61K 31/519;

Publication

European Patent Bulletin

Issue number:
202309
Publication date:
01/03/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages